Health TechTalks

Laura Gomez Cadena & Wyn Dobbs

Conversations with innovators on how they are building solutions to improve patient care at the intersection between healthcare, business, and technology

Episodes

  1. Episode 12: Baltimore's Rising Tide in Biotech. A Discussion with Matt Tremblay, CEO of Blackbird Labs

    07/10/2024

    Episode 12: Baltimore's Rising Tide in Biotech. A Discussion with Matt Tremblay, CEO of Blackbird Labs

    Matt Tremblay is the Chief Executive Officer of Blackbird Laboratories, a nonprofit technology development platform, and Managing Director of Wolf Point, an early stage biotech investment fund. Blackbird and Wolf Point aim to catalyze the creation of new medicines and enabling healthcare technologies in Baltimore. Blackbird laboratories is a $100 Million dollar fund started with the support of Ravens owner Steve Bisciotti that seeks to address the funding gap that many early stage research firms face. With research collaborations with Johns Hopkins University, the University of Maryland Baltimore, and the Lieber Institute for Brain Development, Blackbird seeks to utilize the depth of Baltimore’s specialized researchers in this field.  Prior to leading Blackbird, Matt was the chief operating officer of the drug discovery organization Calibr, where he led a team of biologists in the discovery of new therapeutic agents for metabolic, cardiovascular, and autoimmune diseases. In addition to Matt’s role with Blackbird, he serves as an executive advisor of Scripps Research, a San Diego based facility focused on cutting edge biomedical research. *This episode was recorded in January 2024 Learn more about Matt and the excellent work at Blackbird (plus his favorite monolithic structure- Göbekli Tepe!) in the links below: Blackbird WebsiteBiotech accelerator Blackbird Laboratories launches in Baltimore with Ravens owner’s supportRavens’ owner puts up $100 million to turn science into cures — and Baltimore jobs Göbekli Tepe - Megalithic structure

    24 min

About

Conversations with innovators on how they are building solutions to improve patient care at the intersection between healthcare, business, and technology